Nimacimab

CAS No. 2098636-09-8

Nimacimab( —— )

Catalog No. M36817 CAS No. 2098636-09-8

Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 362 Get Quote
5MG 654 Get Quote
10MG 1036 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Nimacimab
  • Note
    Research use only, not for human use.
  • Brief Description
    Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.
  • Description
    Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2098636-09-8
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • [Arg8,des-Gly-NH29]-...

    [Deglycinamide9, Arginine8]-Vasopressin is a Vasopressin analog. [Deglycinamide9, Arginine8]-Vasopressin induces platelet aggregation. [Deglycinamide9, Arginine8]-Vasopressin has hemostatic effect.

  • CEF27,Epstein-Barr V...

    HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).

  • Forsythoside I

    Forsythoside I a caffeoyl phenylethanoid glycoside (CPG) may possess anti-inflammatory activities.